Menachem Sadeh

Prof. Menachem Sadeh

orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 1993 in Neurology
Verified
Journal Article
Closed access
PDF file
YGYochanan Goldhammer
Yochanan Goldhammer
RGRuth Gabizon
Ruth Gabizon
ZMZeev Meiner
Zeev Meiner
Menachem SadehMenachem Sadeh
Menachem Sadeh
We report the first family among the Jewish population in Israel with Gerstmann-Straussler-Scheinker disease. A proline-for-leucine substitution at the codon 102 of the prion protein (PrP) gene was demonstrated. This mutation has been reported in families with the ataxic form of the disease.

24 November 2023 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
Menachem SadehMenachem Sadeh
Menachem Sadeh
ADAmir Dory
Amir Dory
DLDorit Lev
Dorit Lev
KYKeren Yosovich
Keren Yosovich
RDRon Dabby
Ron Dabby

3 April 2021 in neurogenetics
Verified
Journal Article
Closed access
PDF file
Menachem SadehMenachem Sadeh
Menachem Sadeh
DRDolev Rahat
Dolev Rahat
VMVardiella Meiner
Vardiella Meiner
YFYakov Fellig
Yakov Fellig
MAMichael Arad
Michael Arad
ALAlexander Lossos
Alexander Lossos

1 September 2021 in Neuromuscular Disorders
Verified
Journal Article
Closed access
TATayir Alon
Tayir Alon
Menachem SadehMenachem Sadeh
Menachem Sadeh
DLDorit Lev
Dorit Lev
RDRon Dabby
Ron Dabby

6 November 1998 in Human Heredity
Verified
Journal Article
Closed access
PDF file
MMMarisa M. Menold
Marisa M. Menold
Menachem SadehMenachem Sadeh
Menachem Sadeh
FLFelicia Lennon
Felicia Lennon
IBIlan Blatt
Ilan Blatt
YGYochanan Goldhammer
Yochanan Goldhammer
MPMargaret A. Pericak-Vance
Margaret A. Pericak-Vance
Congenital myasthenic syndromes (CMS) define a diverse group of disorders, all of which compromise neuromuscular transmission. Symptoms can be present at birth or appear during childhood, and can range in severity. Both autosomal dominant and recessive forms exist, and a number of clinical subtypes have been described. The cause of many cases of CMS has been traced to mutations in the genes for the acetylcholine receptor (AChR) subunits, previously mapped to chromosomes 2 and 17. Recently, an additional form of CMS known as familial infantile myasthenia (FIM) was linked to chromosome 17p. The gene for FIM has not yet been identified. We examined the DNA from 5 families of Iranian Jewish origin (6 affected individuals) who have been diagnosed with a phenotypically unique form of CMS. Four of the families are consanguinous, and all families originate from the same geographical region, thus it is highly likely that they would carry the same ancestral CMS mutation. We examined these families for linkage to the regions on chromosomes 2 and 17 containing the AChR subunit genes, and to the region on 17p to which FIM was localized. Our data excludes linkage to these regions, suggesting that the clinical differences seen among patients with CMS correlate with locus heterogeneity, and that a defect in a different gene is responsible for the CMS in these patients.

1 January 2019 in Journal of Clinical Neuroscience
Verified
Journal Article
Closed access
OBOrtal Barel
Ortal Barel
EKElena Kogan
Elena Kogan
Menachem SadehMenachem Sadeh
Menachem Sadeh
NKNitzan Kol
Nitzan Kol
ONOmri Nayschool
Omri Nayschool
FBFelix Benninger
Felix Benninger